Trump's remarks came a day before the Fed was set to announce its next decision on interest rates.Politicsread more
Democratic Rep. Maxine Waters on Tuesday requested that Facebook pause its development of Libra, an upcoming cryptocurrency that the company plans to release in 2020.Technologyread more
"I do expect our stock market to be hammered if nothing positive comes of this G-20 meeting ... the most likely outcome is nothing happens," Jim Cramer says.Mad Money with Jim Cramerread more
Union Pacific CEO Lance Fritz tells Jim Cramer that he is optimistic about trade relations with China, Mexico, Japan, and the EU.Mad Money with Jim Cramerread more
The S&P 500 is closing in on its all-time high, and is likely to sail past it, as long as the Fed promises lower interest rates and the trade war calms down.Market Insiderread more
American Airlines pilots plan to tell lawmakers they are still concerned about fixes to grounded Boeing 737 Max planes.Airlinesread more
See which stocks are posting big moves after the bell on June 18.Market Insiderread more
President Donald Trump on Tuesday announced that he will not nominate acting Defense Secretary Patrick Shanahan to hold the position in a permanent capacity. Army Secretary...Politicsread more
But a look at state-by-state data clarifies the scale of Trump's challenge. As the president tries to rally supporters at a 2020 kickoff rally in Orlando on Tuesday, he is...Politicsread more
In a tweet, Trump said that he and Xi "had a very good telephone conversation," and that "our respective teams will begin talks prior to our meeting."Politicsread more
A Bloomberg News report Tuesday morning said the White House had looked at such a move in February.Marketsread more
In fact, the 2018 midterm elections could be pivotal for the legalization of cannabidiol, commonly known as CBD, a component of the cannabis plant that is not psychoactive and widely used in medical marijuana products, Sands said.
"We expect [CBD] to become legalized potentially as soon as shortly after this election because there's a provision in the farm bill that will actually legalize CBD, the non-psychoactive component," Sands told "Mad Money" host in an exclusive interview.
Sands, whose alcohol distributor boasts popular brands including Corona and Modelo, said Constellation will work with Canopy on non-alcoholic cannabis drinks that resemble beer, champagne, spirits, water and tea.
"I think you'll see a lot of beverages introduced, probably non-alcoholic or in, I would say, most cases, non-alcoholic, to take advantage of at least the CBD legalization," the CEO said.
And while products containing tetrahydrocannabinol, or THC, could still be several years out from hitting U.S. shelves, Sands said the political scene was becoming more accepting to the idea of what could be a several hundred-billion-dollar industry.
"THC-containing cannabis, that's going to be some time off, but I would say that the political front is developing very quickly there," he told Cramer. "In the United States, we believe that it's an inevitability that cannabis will be decriminalized at the federal level. And, as we already know, a lot of states have legalized it recreationally."
Beyond that, Constellation's stake in Canopy allows the beverage producer to "play in" international markets that have moved faster on cannabis legalization than the United States, Sands said.
"You shouldn't lose sight of the international opportunity. There's huge countries — UK is looking at medical legalization. Germany has already legalized medical marijuana," the CEO said. "These are all places, given our Canopy investment, that we can play in. We think it's important to be able to play in all channels and in all segments, not just beverages and not just recreational."
Shares of Constellation Brands surged 5.38 percent on Thursday after the company well above Wall Street's expectations and raised its full-year forecast. The stock settled at $222.10 a share.